Campylobacter infections in human beings.
D000583:Amikacin / Q000627:therapeutic use; D002167:Campylobacter / Q000302:isolation & purification*; D002169:Campylobacter Infections / Q000188:drug therapy / Q000382:microbiology*; D002168:Campylobacter fetus / Q000302:isolation & purification*; D002437:Cefazolin / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D008875:Middle Aged
D004917:Erythromycin; D000583:Amikacin; D002437:Cefazolin